KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Short-term Investments (2022)

TherapeuticsMD (TXMD) has disclosed Short-term Investments for 1 consecutive years, with $11.2 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Short-term Investments changed N/A year-over-year to $11.2 million, compared with a TTM value of $11.2 million through Dec 2022, changed N/A, and an annual FY2022 reading of $11.2 million, changed N/A over the prior year.
  • Short-term Investments was $11.2 million for Q4 2022 at TherapeuticsMD, roughly flat from $11.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $11.2 million in Q2 2022 and bottomed at $11.2 million in Q2 2022.